TOX expression decreases with progression of colorectal cancers and is associated with CD4 T-cell density and Fusobacterium nucleatum infection
Authors:
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 79, 93-101
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Sichuan Science and Technology Agency (201565.)
This publication has 28 references indexed in Scilit:
- Breast cancer risk–associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expressionNature Genetics, 2012
- Differential Epigenetic Regulation of TOX Subfamily High Mobility Group Box Genes in Lung and Breast CancersPLOS ONE, 2012
- The many roles of TOX in the immune systemCurrent Opinion in Immunology, 2012
- TOX Is Required for Development of the CD4 T Cell Lineage Gene ProgramThe Journal of Immunology, 2011
- Genomic analysis identifies association of Fusobacterium with colorectal carcinomaGenome Research, 2011
- Primary Central Nervous System Lymphomas: A Validation Study of Array-Based Comparative Genomic Hybridization in Formalin-Fixed Paraffin-Embedded Tumor SpecimensClinical Cancer Research, 2011
- Fusobacterium nucleatumOuter Membrane Proteins Fap2 and RadD Induce Cell Death in Human LymphocytesInfection and Immunity, 2010
- Longitudinal Outcome Study of Sessile Serrated Adenomas of the Colorectum: An Increased Risk for Subsequent Right-sided Colorectal CarcinomaAmerican Journal of Surgical Pathology, 2010
- probeCheck – a central resource for evaluating oligonucleotide probe coverage and specificityEnvironmental Microbiology, 2008
- Development of all CD4 T lineages requires nuclear factor TOXJournal of Experimental Medicine, 2008